7. P.W.S. Hengh, L.W. Chan, and L. Zhu, "Effects of Process Variables and their Interactions on Melt Pelletization in a High
Shear Mixer," Stp. Pharm. Sci.
10 (2), 165–172 (2000).
8. R.C. Rowe, P.J. Sheskey, and P.J. Weller, "Polyoxyethylene Stearates," in Handbook of Pharmaceutical Excipients , (Pharmaceutical Press, London, 4th ed., 2000), pp. 284–287.
9. R.L. Jackson and M.D. Jason, "Analgesic-Antipyretic and Anti-Inflammatory Agents and Drugs Employed in the Treatment of
Gout," in Goodman & Gilman's The Pharmacological Basis of Therapeutics , J.G. Hardman and L.E. Limbird, Eds. (McGraw-Hill, New York, 2001), pp. 713–714.
10. N.B. Naidu et al., "Physico-Chemical Characterization and Dissolution Properties of Meloxicam–Cyclodextrin Binary Systems,"
J. Pharm. Biomed. Anal.
35 (1), 75–86 (2004).
11. M.M. Ghorab et al., "Tablet Formulation Containing Meloxicam and -Cyclodextrin: Mechanical Characterization and Bioavailability
Evaluation," AAPS PharmSciTech.
5 (4), E59 (2004).
12. N. Seedher and S. Bhatia, "Solubility Enhancement of Cox-2 Inhibitors Using Various Solvent Systems," AAPS PharmSciTech.
4
(3), E1–E6 (2003).
13. R.G. Cantera, M.G. Leza, and C.M. Bachiller, "Solid Phases of Tenoxicam," J. Pharm. Sci.
91 (10), 2240–2251 (2002)
14. Hazi Valizadeh, Ali Nokhodchi, and Nahid Qarakhani, "Physiological Characterisation of Solid Dispersion of Indomethacin
with pEG 6000, Myrj-52, Lactose, Sorbitol, Dextrin, and Eudragit E100," Drug Dev. Ind. Pharm.
30 (3), 303–317 (2004).
|
